Voyager Therapeutics (VYGR) Cash from Investing Activities Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.21% |
| Dec 31, 2025 | 33.27% |
| Sep 30, 2025 | 4.98% |
| Jun 30, 2025 | 25.00% |
| Mar 31, 2025 | -17.68% |
| Dec 31, 2024 | -24.80% |
| Sep 30, 2024 | 23.27% |
| Jun 30, 2024 | -65.58% |
| Mar 31, 2024 | 6.81% |
| Dec 31, 2023 | -1.29% |
| Sep 30, 2023 | -165.81% |
| Jun 30, 2023 | 16.11% |
| Mar 31, 2023 | -24.33% |
| Dec 31, 2022 | 17.44% |
| Sep 30, 2022 | 70.82% |
| Jun 30, 2022 | -24.05% |
| Mar 31, 2022 | -24.31% |
| Dec 31, 2021 | 16.82% |
| Sep 30, 2021 | 16.75% |
| Jun 30, 2021 | -12.13% |
| Mar 31, 2021 | 23.46% |
| Dec 31, 2020 | 26.39% |
| Sep 30, 2020 | 35.70% |
| Jun 30, 2020 | 53.50% |
| Mar 31, 2020 | 273.68% |
| Dec 31, 2019 | 95.04% |